Your Article Summary
See Latest ArticlesImpact of Heterogeneity of Human Peripheral Blood Monocyte Subsets on Myocardial Salvage in Patients With Primary Acute Myocardial Infarction
JACC - Journal of the American College of Cardiology, 07/02/09
Tsujioka H et al. - The peak levels of CD14+CD16– monocytes affect both the extent of myocardial salvage and the recovery of left ventricular function after AMI, indicating that the manipulation of monocyte heterogeneity could be a novel therapeutic target for salvaging ischemic damage.
Related Articles
Clinical Effects of Hypertension on the Mortality of Patients with Acute Myocardial Infarction
Journal of Korean Medical Science, 10/05/09
Relevance Score: 70%
Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting and Bare Metal Stents in Acute Myocardial Infarction. The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Intravascular Ultrasound Substudy
Circulation, 11/02/09
Relevance Score: 69%
The Chemokine Network in Relation to Infarct Size and Left Ventricular Remodeling Following Acute Myocardial Infarction
The American Journal of Cardiology, 10/26/09
Relevance Score: 69%
Clinical Benefit of Early Reperfusion Therapy in Patients With ST-Elevation Myocardial Infarction Usually Excluded from Randomized Clinical Trials (Results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] Registry)
The American Journal of Cardiology, 10/13/09
Relevance Score: 69%
Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial
American Heart Journal, 10/08/09
Relevance Score: 69%
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
Blood Pressure, 12/11/09
Cardiovascular and Economic Outcomes After Initiation of Lipid-Lowering Therapy With Atorvastatin vs Simvastatin in an Employed Population
Mayo Clinic Proceedings, 12/11/09
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09